NEW YORK (GenomeWeb) – Sequenom Chief Medical Officer Allan Bombard plans to retire in June, the company said in a filing with the US Securities and Exchange Commission this week. Bombard has served as the firm's CMO since early 2009, and as one of its CLIA/CAP lab directors since 2010.